| Companies sponsors |
AstraZeneca (osimertinib) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Roy Castle Lung Cancer Foundation |
| Professional groups |
Association of Cancer Physicians |
| |
British Thoracic Oncology Group |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Associated guideline groups |
None |
| Comparator companies |
Amarox (erlotinib) (confidentiality agreement not signed, not participating) |
| |
AstraZeneca (gefitinib, osimertinib) (confidentiality agreement not signed, not participating) |
| |
Boehringer Ingelheim (afatinib) (confidentiality agreement not signed, not participating) |
| |
Cipla EU (gefitinib) (confidentiality agreement not signed, not participating) |
| |
Genus Pharmaceuticals (gefitinib) (confidentiality agreement not signed, not participating) |
| |
Glenmark Pharmaceuticals (erlotinib) (confidentiality agreement not signed, not participating) |
| |
Mylan (erlotinib) (confidentiality agreement not signed, not participating) |
| |
Pfizer (dacomitinib) (confidentiality agreement not signed, not participating) |
| |
Roche (erlotinib) (confidentiality agreement not signed, not participating) |
| |
Sandoz (erlotinib, gefitinib) (confidentiality agreement not signed, not participating) |
| |
Zentiva (erlotinib) (confidentiality agreement not signed, not participating) |
| |
Other relevant companies |
| |
Aspire Pharma (pemetrexed) (confidentiality agreement not signed, not participating) |
| |
Dr Reddy’s Laboratories (pemetrexed) (confidentiality agreement not signed, not participating) |
| |
Eli Lilly (pemetrexed) (confidentiality agreement not signed, not participating) |
| |
Genus Pharmaceuticals (pemetrexed) (confidentiality agreement not signed, not participating) |
| |
Pfizer (carboplatin, cisplatin, pemetrexed) (confidentiality agreement not signed, not participating) |
| |
Sandoz (cisplatin, pemetrexed) (confidentiality agreement not signed, not participating) |
| |
Seacross Pharmaceuticals (pemetrexed) (confidentiality agreement not signed, not participating) |
| |
Sun Pharma (pemetrexed) (confidentiality agreement not signed, not participating) |
| |
Zentiva (pemetrexed) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |